Alogliptin added to sulfonylurea therapy in patients with type 2 diabetes reduces HbA1c without increasing hypoglycemia

被引：0

|

作者：

Pratley, Richard

Kipnes, Mark

Fleck, Penny

Wilson, Craig

Mekki, Qais

机构：

来源：

DIABETES | 2008年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A133 / A133

页数：1

相关论文

共 50 条

[21] SEVERE HYPOGLYCEMIA IN TYPE-1 DIABETES IS RELATED TO HBA1C, DIABETES DURATION AND INSULIN THERAPY STRATEGY
BAUER, I
DASSIE, A
DONATH, P
BRUCK, S
SCHERNTHANER, G
DIABETOLOGIA, 1992, 35 : A183 - A183
[22] Depressive symptoms and HbA1c in patients with Type 1 and Type 2 diabetes
Kawada, T.
DIABETIC MEDICINE, 2014, 31 (06) : 759 - 760
[23] THE IMPACT OF BASELINE HBA1C AND HBA1C TRAJECTORIES ON TIME TO THERAPY ESCALATION IN TYPE 2 DIABETES MELLITUS
McEwan, P.
Foos, V
Larnotte, M.
VALUE IN HEALTH, 2015, 18 (07) : A698 - A698
[24] Initiation of combination therapy in type 2 diabetes patients with high HbA1c at diagnosis
Klok, R.
Gulati, T.
Rajpathak, S.
Pal, S.
Yang, L.
Bandyopadhyay, A.
Khunti, K.
DIABETOLOGIA, 2019, 62 : S177 - S177
[25] Added value of diabetes risk genes to the prediction of HbA1c levels in patients initiating metformin or sulfonylurea derivatives
Martono, D.
Heerspink, H.
Hak, E.
Denig, P.
Wilffert, B.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S15 - S15
[26] Initiation of combination therapy in type 2 diabetes patients with high HbA1c at diagnosis
Klok, R. M.
Kumar, A.
Rajpathak, S.
Fu, A. Z.
Khunti, K.
DIABETOLOGIA, 2018, 61 : S177 - S177
[27] Achieving Reductions in HbA1c ≥1% without Hypoglycemia with Saxagliptin Combination Therapy: Post Hoc Analysis of 4 Randomized Controlled Studies in Patients with Type 2 Diabetes
Karyekar, Chetan
Frederich, Robert
Donovan, Mark
Ravichandran, Shoba
DIABETES, 2011, 60 : A594 - A595
[28] Type 2 diabetes and HbA1c goal: time for individualised therapy
Jabbour, S.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (10) : 1409 - 1409
[29] COST OF ANTIHYPERGLYCEMIC THERAPY IN TYPE 2 DIABETES PATIENTS DEPENDING ON HBA1C AND BMI VALUES
Sorg, A.
Dombrowski, S.
Kostev, K.
VALUE IN HEALTH, 2016, 19 (07) : A665 - A665
[30] Seasonal variation in HbA1c in patients with Type 2 diabetes mellitus
Carney, TA
Guy, SP
Helliwell, CD
DIABETIC MEDICINE, 2000, 17 (07) : 554 - 555

← 1 2 3 4 5 →